Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joseph T. Marakovits"'
Autor:
Stephen E. Webber, Joseph T. Marakovits, Peter S. Dragovich, Thomas J. Prins, Ru Zhou, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Babu Srinivasan, Terry Moran, Clifford E. Ford, Mary A. Brothers, James E.V. Harr, James W. Meador, Rose Ann Ferre, Stephen T. Worland
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 11:2683-2686
Novel tripeptidyl C-terminal Michael acceptors with an ester replacement of the P(2)-P(3) amide bond were investigated as irreversible inhibitors of the human rhinovirus (HRV) 3C protease (3CP). When screened against HRV serotype-14 the best compound
Autor:
Babine Robert E, Edward L. Brown, David A. Matthews, Susan L. Binford, Stephen T. Worland, Shella A. Fuhrman, Amy K. Patick, James E. V. Harr, Reich Siegfried Heinz, Joseph T. Marakovits, Thomas J. Prins, Caroline A. Lee, Wallace Michael B, Peter S. Dragovich, Littlefield Ethel S, and Dorothy M. DeLisle, James W. Meador, Rose Ann Ferre, Clifford E. Ford, Ru Zhou, Stephen E. Webber, Jayashree Tikhe
Publikováno v:
Journal of Medicinal Chemistry. 41:2819-2834
The structure-based design, chemical synthesis, and biological evaluation of various peptide-derived human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds are comprised of an ethyl propenoate Michael acceptor moiety and a
Autor:
R.Timothy Mulcahy, Richard F. Borch, Joseph T. Marakovits, Jerry J. Gipp, Carolyn Joswig, Jiwen Liu, James P. Schmidt
Publikováno v:
ChemInform. 31
Autor:
Ru Zhou, Stephen E. Webber, Thomas J. Prins, Joseph T. Marakovits, Rose Ann Ferre, Edward L. Brown, Caroline A. Lee, James E. V. Harr, Peter S. Dragovich, Tove Tuntland, Benjamin J. Burke, Amy K. Patick, Clifford E. Ford, Shella A. Fuhrman, Paul A. Rejto, Thomas F. Hendrickson, Maha Kosa, Stephen T. Worland, James W. Meador, David A. Matthews
Publikováno v:
Journal of medicinal chemistry. 42(7)
The structure-based design, chemical synthesis, and biological evaluation of various human rhinovirus (HRV) 3C protease (3CP) inhibitors which incorporate P1 lactam moieties in lieu of an L-glutamine residue are described. These compounds are compris
Autor:
Peter S. Dragovich, Stephen E. Webber, Robert E. Babine, Shella A. Fuhrman, Amy K. Patick, David A. Matthews, Caroline A. Lee, Siegfried H. Reich, Thomas J. Prins, Joseph T. Marakovits, Ethel S. Littlefield, Ru Zhou, Jayashree Tikhe, Clifford E. Ford, Michael B. Wallace, James W. Meador, Rose Ann Ferre, Edward L. Brown, Susan L. Binford, James E. V. Harr, Dorothy M. DeLisle, Stephen T. Worland
Publikováno v:
Journal of medicinal chemistry. 41(15)
The structure-based design, chemical synthesis, and biological evaluation of peptide-derived human rhinovirus (HRV) 3C protease (3CP) inhibitors are described. These compounds incorporate various Michael acceptor moieties and are shown to irreversibl